Quinapril And Hydrochlorothiazide 20/12.5 Tablet
Product Images NDC 69097-829

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Quinapril And Hydrochlorothiazide 20/12.5 (NDC 69097-829). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (4d5399c0 8a0b 4140 Bade 1a338866b769 01)

FDA Label Image

Image (4d5399c0 8a0b 4140 Bade 1a338866b769 02)

FDA Label Image

Image (4d5399c0 8a0b 4140 Bade 1a338866b769 03)

This text is a list of medical conditions or symptoms. It includes terms related to respiratory, digestive, and neurological systems, such as chest pain, vertigo, dyspepsia, and respiratory distress. It seems to refer to a chart or record-keeping system for patients who are monitored or treated for these conditions.*

FDA Label Image

Image (4d5399c0 8a0b 4140 Bade 1a338866b769 04)

This appears to be a medical report and lists various symptoms and conditions related to different body systems. It also mentions a warning about angioedema being reported in patients receiving quinapl.*

FDA Label Image

Image (4d5399c0 8a0b 4140 Bade 1a338866b769 05)

FDA Label Image

Quinapril And Hydrochlorothiazide 10 mg

FDA Label Image

Quinapril And Hydrochlorothiazide 20 mg

This is a prescription drug with the NDC code 69097-829-05. The drug contains Quinapril HCI 20 mg and Hydrochlorothiazide 12.5 mg in each tablet, and is manufactured by Cipla for Cipla USA, Inc. The tablets need to be stored at a controlled-room temperature. The dosage and usage details can be found in the prescribing information. The text also has some manufacturing details.*

FDA Label Image

Quinapril And Hydrochlorothiazide 25

This is a description of a medication called Quinapril and Hydrochlorothiazide. It is produced by Cipla and each tablet contains 20mg of quinapril HC1, USP and 25mg of hydrochlorothiazide, USP. It is a prescription-only medication and comes in a container with 90 tablets. Dosage and usage instructions can be found alongside prescribing information. It should be stored at a controlled room temperature between 20°C and 25°C. The medication is manufactured by InvaGen Pharmaceuticals, a subsidiary of Cipla.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.